Tjan-Heijnen VC - Search Results

1

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, Foekens JA, Sweep CG. Manders P, et al. Br J Cancer. 2002 Sep 23;87(7):772-8. doi: 10.1038/sj.bjc.6600555. Br J Cancer. 2002. PMID: 12232762 Free PMC article.

2

Treatment in germ cell tumours: state of the art.

Tjan-Heijnen VC, Oosterhof GO, de Wit R, De Mulder PH. Tjan-Heijnen VC, et al. Eur J Surg Oncol. 1997 Apr;23(2):110-7. doi: 10.1016/s0748-7983(97)80002-9. Eur J Surg Oncol. 1997. PMID: 9158183 Review.

3

Cutaneous infection due to Mycobacterium abscessus. A case report.

Vogels MT, Tjan-Heijnen VC, Alkemade JA, Beex LV, Muytjens HL. Vogels MT, et al. Acta Derm Venereol. 1997 May;77(3):222-4. doi: 10.2340/0001555577222224. Acta Derm Venereol. 1997. PMID: 9188876 Free article.

4

[Chemotherapy in metastasized breast cancer].

Beex LV, Tjan-Heijnen VC, Ottevanger PB. Beex LV, et al. Ned Tijdschr Geneeskd. 1999 Jan 2;143(1):59-60. Ned Tijdschr Geneeskd. 1999. PMID: 10086103 Dutch. No abstract available.

5

Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands.

van Dijck JA, Festen J, de Kleijn EM, Kramer GW, Tjan-Heijnen VC, Verbeek AL; Working Group on Lung Cancer of the Comprehensive Cancer Centre East. van Dijck JA, et al. Lung Cancer. 2001 Oct;34(1):19-27. doi: 10.1016/s0169-5002(01)00214-8. Lung Cancer. 2001. PMID: 11557109

6

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.

Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV. Tjan-Heijnen VC, et al. Breast Cancer Res Treat. 2001 Nov;70(2):81-8. doi: 10.1023/a:1012938825396. Breast Cancer Res Treat. 2001. PMID: 11768607 Review.

7

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.

Manders P, Bult P, Sweep CG, Tjan-Heijnen VC, Beex LV. Manders P, et al. Breast Cancer Res Treat. 2003 Jan;77(1):77-84. doi: 10.1023/a:1021138801890. Breast Cancer Res Treat. 2003. PMID: 12602906

8

Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.

de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. de Widt-Levert L, et al. Eur J Surg Oncol. 2003 Apr;29(3):216-20. doi: 10.1053/ejso.2002.1401. Eur J Surg Oncol. 2003. PMID: 12657229

9

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.

Span PN, Tjan-Heijnen VC, Manders P, Beex LV, Sweep CG. Span PN, et al. Oncogene. 2003 Jul 31;22(31):4898-904. doi: 10.1038/sj.onc.1206818. Oncogene. 2003. PMID: 12894232

10

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.

Manders P, Beex LV, Tjan-Heijnen VC, Span PN, Sweep CG. Manders P, et al. Cancer. 2003 Nov 15;98(10):2125-32. doi: 10.1002/cncr.11764. Cancer. 2003. PMID: 14601081 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page